These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25425646)

  • 1. A novel MEK-ERK-AMPK signaling axis controls chemokine receptor CCR7-dependent survival in human mature dendritic cells.
    López-Cotarelo P; Escribano-Díaz C; González-Bethencourt IL; Gómez-Moreira C; Deguiz ML; Torres-Bacete J; Gómez-Cabañas L; Fernández-Barrera J; Delgado-Martín C; Mellado M; Regueiro JR; Miranda-Carús ME; Rodríguez-Fernández JL
    J Biol Chem; 2015 Jan; 290(2):827-40. PubMed ID: 25425646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mammalian Sterile 20-like 1 Kinase Controls Selective CCR7-Dependent Functions in Human Dendritic Cells.
    Torres-Bacete J; Delgado-Martín C; Gómez-Moreira C; Simizu S; Rodríguez-Fernández JL
    J Immunol; 2015 Aug; 195(3):973-81. PubMed ID: 26116501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR7-dependent stimulation of survival in dendritic cells involves inhibition of GSK3beta.
    Escribano C; Delgado-Martín C; Rodríguez-Fernández JL
    J Immunol; 2009 Nov; 183(10):6282-95. PubMed ID: 19841191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine CXCL12 uses CXCR4 and a signaling core formed by bifunctional Akt, extracellular signal-regulated kinase (ERK)1/2, and mammalian target of rapamycin complex 1 (mTORC1) proteins to control chemotaxis and survival simultaneously in mature dendritic cells.
    Delgado-Martín C; Escribano C; Pablos JL; Riol-Blanco L; Rodríguez-Fernández JL
    J Biol Chem; 2011 Oct; 286(43):37222-36. PubMed ID: 21878648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
    Lee SY; Shin SJ; Kim HS
    Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor contributes to the MEK/ERK-dependent maintenance of the immature state of human dendritic cells.
    Aguilera-Montilla N; Chamorro S; Nieto C; Sánchez-Cabo F; Dopazo A; Fernández-Salguero PM; Rodríguez-Fernández JL; Pello OM; Andrés V; Cuenda A; Alonso B; Domínguez-Soto A; Sánchez-Ramón S; Corbí AL
    Blood; 2013 Apr; 121(15):e108-17. PubMed ID: 23430108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR7/CCL19 controls expression of EDG-1 in T cells.
    Shannon LA; McBurney TM; Wells MA; Roth ME; Calloway PA; Bill CA; Islam S; Vines CM
    J Biol Chem; 2012 Apr; 287(15):11656-64. PubMed ID: 22334704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
    Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
    Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
    Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
    Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
    Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Chemokine Receptor CCR7 Uses Distinct Signaling Modules With Biased Functionality to Regulate Dendritic Cells.
    Rodríguez-Fernández JL; Criado-García O
    Front Immunol; 2020; 11():528. PubMed ID: 32351499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-alpha induced endothelial apoptosis.
    Grethe S; Pörn-Ares MI
    Cell Signal; 2006 Apr; 18(4):531-40. PubMed ID: 15972258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
    Guenther MK; Graab U; Fulda S
    Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin inhibits neutrophil apoptosis via activation of AMP kinase, PKB and ERK 1/2 MAP kinase.
    Rossi A; Lord JM
    Apoptosis; 2013 Dec; 18(12):1469-80. PubMed ID: 23982477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
    Kim EJ; Juhnn YS
    J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis.
    Otero C; Eisele PS; Schaeuble K; Groettrup M; Legler DF
    J Cell Sci; 2008 Aug; 121(Pt 16):2759-67. PubMed ID: 18664492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
    Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
    Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK1/2 activation modulates pyocyanin-induced toxicity in A549 respiratory epithelial cells.
    Forbes A; Davey AK; Perkins AV; Grant GD; McFarland AJ; McDermott CM; Anoopkumar-Dukie S
    Chem Biol Interact; 2014 Feb; 208():58-63. PubMed ID: 24316274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.